Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,306
Closed -$219K 702
2026
Q1
$219K Buy
+4,306
New +$201K 0.01% 572
2020
Q2
Sell
-13,550
Closed -$413K 206
2020
Q1
$413K Buy
13,550
+550
+4% +$12.7K 0.23% 76
2019
Q4
$254K Buy
+13,000
New +$231K 0.12% 134

Other funds holding MRNA

Certuity's MRNA Position: Q2 2026 in Review

Certuity sold out of Moderna (MRNA) in Q2 2026, closing a stake of 4,306 shares — an estimated $219K sold.

Certuity first reported a position in MRNA in Q4 2019 and held it in 3 quarters. The position peaked at $413K in Q1 2020. 247 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Certuity reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Certuity sold 4,306 Moderna shares in Q2 2026, an estimated $219K.
  • Certuity first reported a position in Moderna in Q4 2019 and held it in 3 quarters.
  • Certuity's Moderna position peaked at $413K in Q1 2020.
  • 247 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.